Intensive hydroxyurea dosing in very young children with sickle cell anemia

Blood Adv. 2023 Nov 28;7(22):6931-6935. doi: 10.1182/bloodadvances.2022009613.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / therapeutic use
  • Child
  • Child, Preschool
  • Humans
  • Hydroxyurea* / therapeutic use

Substances

  • Hydroxyurea
  • Antisickling Agents